TMCnet

Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases

Galapagos intends to enter into a strategic collaboration with Gilead following Gilead's acquisition of Ouro Medicines. New ...

Bionano Genomics (BNGO) Earnings Transcript

OGM VIA customers represent a meaningful software revenue stream and a natural on-ramp to broader Bionano Genomics, Inc.

Galapagos NV: Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases

Galapagos intends to enter into a strategic collaboration with Gilead following Gilead's acquisition of Ouro Medicines New partnership structure would achieve meaningfully improved financial terms ...

A Digital Enterprise Without Cybersecurity Is A Body Without Immunity

Just as the immune system quietly protects the human body every day, cybersecurity must quietly protect the digital ...

Will letting employers keep final salary pension surpluses endanger saver funds? Steve Webb replies

Is this not highly risky in terms of the future security of the pension plan? The Pension Schemes Bill seems heavily loaded ...
JCN Newswire

Results from Real-World, Long-Term Treatment Persistence with LEQEMBI(R) (lecanemab-irmb) in the United States Presented at AD/PD(TM) 2026

Real-World LEQEMBI Data Shows Patients Choose to Stay on Long-Term Treatment TOKYO and CAMBRIDGE, Mass., Mar 23, 2026 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that new ...